Income Statement Revolution Medicines, Inc.

Equities

RVMD

US76155X1000

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 18:06:28 13/03/2026 GMT			5-day change	1st Jan Change
96.19 ^USD	+1.18%		-2.31%	+20.69%

03-04	Revolution Medicines Insider Sold Shares Worth $3,644,354, According to a Recent SEC Filing	MT
03-03	Revolution Medicines, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 09:50 AM

c29c.A8wO2XhaW7UX_GxqDiS5DcG8i89Q8mvexaYc8ola4ns.RPR0oTcVLIImml4BZEHpPZTSx5wAm1LtovVFodEutB9HolirQTMz9HubIQ

Published financial data: REVOLUTION MEDICINES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	29.39M	35.38M	11.58M	-	-
Total Revenues	29.39M	35.38M	11.58M	-	-
Cost of Goods Sold, Total	187M	253M	411M	592M	987M
Gross Profit	-158M	-218M	-400M	-592M	-987M
Selling General & Admin Expenses, Total	30.45M	40.59M	62.02M	97.3M	195M
Other Operating Expenses, Total	30.45M	40.59M	62.02M	97.3M	195M
Operating Income	-188M	-258M	-462M	-690M	-1.18B
Interest Expense, Total	-12K	-	-303K	-	-24.23M
Interest And Investment Income	929K	9.15M	47.48M	86.88M	90.69M
Net Interest Expenses	917K	9.15M	47.18M	86.88M	66.46M
Other Non Operating Income (Expenses)	-	-	115K	1.8M	-15.4M
EBT, Excl. Unusual Items	-187M	-249M	-414M	-601M	-1.13B
Merger & Related Restructuring Charges	-	-	-25.5M	-	-
EBT, Incl. Unusual Items	-187M	-249M	-440M	-601M	-1.13B
Income Tax Expense	-	-420K	-3.52M	-753K	-
Earnings From Continuing Operations	-187M	-249M	-436M	-600M	-1.13B
Net Income to Company	-187M	-249M	-436M	-600M	-1.13B
Net Income - (IS)	-187M	-249M	-436M	-600M	-1.13B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-187M	-249M	-436M	-600M	-1.13B
Net Income to Common Excl. Extra Items	-187M	-249M	-436M	-600M	-1.13B
Per Share Items
Net EPS - Basic	-2.57	-3.08	-3.86	-3.58	-5.95
Basic EPS - Continuing Operations	-2.57	-3.08	-3.86	-3.58	-5.95
Basic Weighted Average Shares Outstanding	72.81M	80.63M	113M	168M	190M
Net EPS - Diluted	-2.57	-3.08	-3.86	-3.58	-5.95
Diluted EPS - Continuing Operations	-2.57	-3.08	-3.86	-3.58	-5.95
Diluted Weighted Average Shares Outstanding	72.81M	80.63M	113M	168M	190M
Normalized Basic EPS	-1.61	-1.93	-2.29	-2.24	-3.72
Normalized Diluted EPS	-1.61	-1.93	-2.29	-2.24	-3.72
Supplemental Items
EBITDA	-185M	-254M	-457M	-683M	-1.17B
EBITA	-188M	-258M	-462M	-690M	-1.18B
EBIT	-188M	-258M	-462M	-690M	-1.18B
EBITDAR	-182M	-248M	-448M	-671M	-1.16B
Total Revenues (As Reported)	29.39M	35.38M	11.58M	-	-
Effective Tax Rate - (Ratio)	-	0.17	0.8	0.13	-
Current Domestic Taxes	-	-	112K	27K	-
Current Foreign Taxes	-	-	212K	-42K	-
Total Current Taxes	-	-	324K	-15K	-
Deferred Domestic Taxes	-	-419K	-3.86M	-721K	-
Deferred Foreign Taxes	-	-	17K	-17K	-
Total Deferred Taxes	-	-419K	-3.85M	-738K	-
Normalized Net Income	-117M	-156M	-259M	-376M	-707M
Supplemental Operating Expense Items
General and Administrative Expenses	30.45M	40.59M	62.02M	97.3M	195M
Research And Development Expense From Footnotes	187M	253M	423M	592M	987M
Net Rental Expense, Total	3.4M	6.4M	8.18M	11.6M	15.48M
Imputed Operating Lease Interest Expense	6.56K	-	261K	-	10.66M
Imputed Operating Lease Depreciation	3.39M	-	7.92M	-	4.82M
Stock-Based Comp., COGS (Total)	11.85M	18.11M	34.13M	50.97M	78.36M
Stock-Based Comp., G&A Exp. (Total)	8.88M	13.08M	27.65M	28.22M	40.03M
Total Stock-Based Compensation	20.72M	31.2M	61.77M	79.2M	118M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	108M	161M	696M	543M	384M
Short Term Investments	469M	484M	1.16B	1.75B	1.64B
Total Cash And Short Term Investments	577M	645M	1.85B	2.29B	2.03B
Accounts Receivable, Total	5.93M	4.67M	1.25M	-	-
Total Receivables	5.93M	4.67M	1.25M	-	-
Prepaid Expenses	6.79M	10.57M	25.07M	38.33M	49.36M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	590M	660M	1.88B	2.33B	2.08B
Gross Property Plant And Equipment	82.05M	88.22M	118M	164M	194M
Accumulated Depreciation	-10.81M	-14.49M	-17.69M	-21.82M	-28.51M
Net Property Plant And Equipment	71.24M	73.74M	100M	142M	165M
Goodwill	14.61M	14.61M	14.61M	14.61M	14.61M
Other Intangibles, Total	59.88M	58.81M	57.74M	56.67M	55.8M
Deferred Charges Long-Term	500K	600K	-	-	-
Other Long-Term Assets, Total	2M	3.99M	10.06M	17.57M	43.78M
Total Assets	738M	812M	2.06B	2.56B	2.35B
Liabilities
Accounts Payable, Total	14.06M	21.31M	61.79M	54.43M	64.62M
Accrued Expenses, Total	27.41M	28.94M	70.8M	96.03M	201M
Current Portion of Leases	6.21M	6.77M	7.37M	12.87M	16.47M
Unearned Revenue Current, Total	12.36M	4.46M	-	-	-
Other Current Liabilities	311K	505K	3.9M	583K	7.86M
Total Current Liabilities	60.35M	61.98M	144M	164M	290M
Long-Term Debt	-	-	-	-	268M
Long-Term Leases	60.42M	57.43M	80.58M	123M	142M
Unearned Revenue Non Current	6.57M	-	-	-	-
Deferred Tax Liability Non Current	7.44M	7.02M	3.12M	2.35M	2.35M
Other Non Current Liabilities	634K	301K	7.97M	3.86M	19.75M
Total Liabilities	135M	127M	236M	293M	723M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	8K	9K	16K	18K	19K
Additional Paid In Capital	1.06B	1.39B	2.96B	4B	4.5B
Retained Earnings	-453M	-701M	-1.14B	-1.74B	-2.87B
Comprehensive Income and Other	-376K	-1.78M	544K	1.32M	3.24M
Total Common Equity	603M	685M	1.83B	2.27B	1.63B
Total Equity	603M	685M	1.83B	2.27B	1.63B
Total Liabilities And Equity	738M	812M	2.06B	2.56B	2.35B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	74.19M	90.49M	165M	186M	198M
ECS Total Common Shares Outstanding	74.14M	90.41M	165M	186M	197M
Book Value / Share	8.13	7.58	11.09	12.19	8.28
Tangible Book Value	528M	612M	1.75B	2.19B	1.56B
Tangible Book Value Per Share	7.12	6.77	10.65	11.8	7.92
Total Debt	66.63M	64.2M	87.94M	136M	427M
Net Debt	-510M	-581M	-1.77B	-2.15B	-1.6B
Debt Equivalent Oper. Leases	27.2M	51.2M	65.46M	92.84M	124M
Account Code - Inventory Valuation	3	-	3	3	3
Machinery, Total	14.98M	21.74M	28.09M	31.44M	39.38M
Full Time Employees	188	246	378	534	883

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-187M	-249M	-436M	-600M	-1.13B
Depreciation & Amortization - CF	6.26M	8.59M	8.24M	10.76M	15.69M
Amortization of Goodwill and Intangible Assets - (CF)	-31K	-31K	-32K	-31K	-30K
Depreciation & Amortization, Total	6.23M	8.56M	8.21M	10.72M	15.66M
Amortization of Deferred Charges, Total - (CF)	1.1M	1.1M	1.1M	1.1M	900K
(Gain) Loss From Sale Of Asset	119K	19K	52K	118K	32K
(Gain) Loss on Sale of Investments - (CF)	3.01M	-3.08M	-22.2M	-44.56M	-27.83M
Stock-Based Compensation (CF)	20.72M	31.2M	61.77M	79.2M	118M
Other Operating Activities, Total	-	-	115K	-4.32M	39.59M
Change In Accounts Receivable	464K	1.26M	3.42M	1.25M	-
Change In Accounts Payable	2.24M	7.29M	32.47M	-6.46M	9.54M
Change in Unearned Revenues	-1.66M	-14.47M	-4.46M	-	-
Change In Deferred Taxes	-	-419K	-3.91M	-762K	-
Change in Other Net Operating Assets	7.68M	-7.14M	9.23M	6.38M	77.29M
Cash from Operations	-147M	-224M	-351M	-557M	-898M
Capital Expenditure	-6.53M	-10.82M	-7.73M	-10.31M	-15.99M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-136M	-13.3M	-335M	-544M	134M
Cash from Investing	-142M	-24.12M	-343M	-554M	118M
Issuance of Common Stock	295M	301M	392M	864M	377M
Repurchase of Common Stock	-	-	-4.03M	-	-
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-424K	42K	841M	95.71M	244M
Cash from Financing	294M	301M	1.23B	959M	622M
Net Change in Cash	4.88M	52.92M	536M	-152M	-158M
Supplemental Items
Levered Free Cash Flow	-84.69M	-133M	-155M	-348M	-523M
Unlevered Free Cash Flow	-84.68M	-133M	-155M	-348M	-508M
Change In Net Working Capital	-11.29M	1.45M	-70.19M	-2.55M	-112M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-18	-20.83	-20.08	-18.66	-30.08
Return on Total Capital	-19.97	-22.76	-21.67	-19.97	-33.14
Return On Equity %	-34.74	-38.63	-34.75	-29.33	-58.07
Return on Common Equity	-34.74	-38.63	-34.75	-29.33	-58.07
Margin Analysis
Gross Profit Margin %	-536.09	-615.3	-3.45K	-	-
SG&A Margin	103.61	114.71	535.59	-	-
EBITDA Margin %	-629.32	-718.88	-3.94K	-	-
EBITA Margin %	-639.81	-730.1	-3.99K	-	-
EBIT Margin %	-639.7	-730.01	-3.99K	-	-
Income From Continuing Operations Margin %	-636.58	-702.95	-3.77K	-	-
Net Income Margin %	-636.58	-702.95	-3.77K	-	-
Net Avail. For Common Margin %	-636.58	-702.95	-3.77K	-	-
Normalized Net Income Margin	-397.86	-440.09	-2.24K	-	-
Levered Free Cash Flow Margin	-288.16	-375.46	-1.34K	-	-
Unlevered Free Cash Flow Margin	-288.14	-375.46	-1.34K	-	-
Asset Turnover
Asset Turnover	0.05	0.05	0.01	-	-
Fixed Assets Turnover	0.55	0.49	0.13	-	-
Receivables Turnover (Average Receivables)	4.77	6.67	3.91	-	-
Short Term Liquidity
Current Ratio	9.77	10.65	13.06	14.2	7.14
Quick Ratio	9.66	10.48	12.89	13.97	6.97
Operating Cash Flow to Current Liabilities	-2.44	-3.62	-2.44	-3.4	-3.09
Days Sales Outstanding (Average Receivables)	76.51	54.69	93.41	-	-
Average Days Payable Outstanding	26.03	25.5	36.87	35.91	22
Long Term Solvency
Total Debt/Equity	11.06	9.37	4.82	6	26.18
Total Debt / Total Capital	9.96	8.57	4.59	5.66	20.75
LT Debt/Equity	10.03	8.38	4.41	5.43	25.18
Long-Term Debt / Total Capital	9.03	7.66	4.21	5.12	19.95
Total Liabilities / Total Assets	18.35	15.61	11.42	11.46	30.72
EBIT / Interest Expense	-15.67K	-	-1.52K	-	-48.8
EBITDA / Interest Expense	-15.13K	-	-1.48K	-	-47.84
(EBITDA - Capex) / Interest Expense	-15.67K	-	-1.51K	-	-48.5
Total Debt / EBITDA	-0.37	-0.26	-0.2	-0.2	-0.37
Net Debt / EBITDA	2.81	2.34	3.94	3.21	1.38
Total Debt / (EBITDA - Capex)	-0.35	-0.25	-0.19	-0.2	-0.36
Net Debt / (EBITDA - Capex)	2.71	2.24	3.87	3.16	1.36
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-31.62	20.38	-67.27	-	-
Gross Profit, 1 Yr. Growth %	76.5	38.17	83.59	48.18	66.72
EBITDA, 1 Yr. Growth %	71.07	37.51	79.55	49.56	71.98
EBITA, 1 Yr. Growth %	69.82	37.37	78.75	49.35	71.47
EBIT, 1 Yr. Growth %	69.84	37.38	78.75	49.35	71.48
Earnings From Cont. Operations, 1 Yr. Growth %	72.98	32.93	75.46	37.52	88.52
Net Income, 1 Yr. Growth %	72.98	32.93	75.46	37.52	88.52
Normalized Net Income, 1 Yr. Growth %	72.39	33.16	66.34	44.99	88.28
Diluted EPS Before Extra, 1 Yr. Growth %	27.75	20.04	25.02	-7.23	66.32
Accounts Receivable, 1 Yr. Growth %	-7.26	-21.18	-73.16	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	96.04	3.51	35.64	41.8	16.54
Total Assets, 1 Yr. Growth %	30.06	10.02	153.93	24.09	-7.97
Tangible Book Value, 1 Yr. Growth %	32.31	15.85	186.68	25.09	-28.85
Common Equity, 1 Yr. Growth %	26.94	13.71	166.52	24.04	-27.98
Cash From Operations, 1 Yr. Growth %	47.09	52.47	56.23	59.01	61.05
Capital Expenditures, 1 Yr. Growth %	122.57	65.69	-28.54	33.37	55.12
Levered Free Cash Flow, 1 Yr. Growth %	45.42	56.85	16.84	124.02	50.5
Unlevered Free Cash Flow, 1 Yr. Growth %	45.52	56.86	16.7	124.29	46.15
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-23.36	-9.27	-37.23	-	-
Gross Profit, 2 Yr. CAGR %	94.35	56.16	59.27	64.94	54.89
EBITDA, 2 Yr. CAGR %	88.82	53.38	57.13	63.87	56.08
EBITA, 2 Yr. CAGR %	86.35	52.74	56.7	63.39	55.78
EBIT, 2 Yr. CAGR %	86.38	52.75	56.71	63.39	55.79
Earnings From Cont. Operations, 2 Yr. CAGR %	98.12	51.64	52.72	55.33	61.01
Net Income, 2 Yr. CAGR %	98.12	51.64	52.72	55.33	61.01
Normalized Net Income, 2 Yr. CAGR %	89.61	51.51	48.83	55.3	60.37
Diluted EPS Before Extra, 2 Yr. CAGR %	-66.07	23.84	22.51	7.69	24.21
Accounts Receivable, 2 Yr. CAGR %	-17.62	-14.5	-54.01	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	215.71	42.45	18.49	38.69	28.55
Total Assets, 2 Yr. CAGR %	82.93	19.62	67.14	77.51	6.87
Tangible Book Value, 2 Yr. CAGR %	51.79	23.81	82.24	89.37	-5.66
Common Equity, 2 Yr. CAGR %	98.73	20.15	74.09	81.82	-5.49
Cash From Operations, 2 Yr. CAGR %	72.23	49.75	54.33	57.61	60.02
Capital Expenditures, 2 Yr. CAGR %	58.79	92.03	8.81	-2.38	43.83
Levered Free Cash Flow, 2 Yr. CAGR %	250.13	51.03	35.37	61.78	80.99
Unlevered Free Cash Flow, 2 Yr. CAGR %	251.81	51.08	35.3	61.78	78.35
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	13.38	-10.91	-35.41	-	-
Gross Profit, 3 Yr. CAGR %	72.08	73.46	64.82	55.48	65.53
EBITDA, 3 Yr. CAGR %	68.93	69.88	61.65	54.57	66.53
EBITA, 3 Yr. CAGR %	67.61	68.34	60.96	54.21	66.04
EBIT, 3 Yr. CAGR %	67.61	68.36	60.97	54.21	66.04
Earnings From Cont. Operations, 3 Yr. CAGR %	64.82	73.45	59.2	47.48	65.69
Net Income, 3 Yr. CAGR %	64.82	73.45	59.2	47.48	65.69
Normalized Net Income, 3 Yr. CAGR %	65.34	68.54	56.3	47.54	65.6
Diluted EPS Before Extra, 3 Yr. CAGR %	-50.54	-48.3	24.23	11.66	24.48
Accounts Receivable, 3 Yr. CAGR %	-6.71	-18.83	-41.9	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	118.04	117.7	40.14	25.8	30.87
Total Assets, 3 Yr. CAGR %	62.94	54.41	53.74	51.34	42.6
Tangible Book Value, 3 Yr. CAGR %	41.57	38.72	63.79	60.76	36.64
Common Equity, 3 Yr. CAGR %	77.13	64.98	56.69	55.49	33.53
Cash From Operations, 3 Yr. CAGR %	395.07	65.37	51.88	55.88	58.75
Capital Expenditures, 3 Yr. CAGR %	63.3	61.06	38.12	16.45	13.92
Levered Free Cash Flow, 3 Yr. CAGR %	72.21	167.91	38.64	60.12	57.93
Unlevered Free Cash Flow, 3 Yr. CAGR %	72.45	168.77	38.62	60.13	56.39
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-10.5	-	-
Gross Profit, 5 Yr. CAGR %	-	52.28	66.84	70	61.72
EBITDA, 5 Yr. CAGR %	-	53.4	64.11	67.45	61.14
EBITA, 5 Yr. CAGR %	-	52.68	63.16	66.34	60.58
EBIT, 5 Yr. CAGR %	-	52.68	63.16	66.36	60.59
Earnings From Cont. Operations, 5 Yr. CAGR %	-	51.53	59.87	65.96	59.92
Net Income, 5 Yr. CAGR %	-	51.53	59.87	65.96	59.92
Normalized Net Income, 5 Yr. CAGR %	-	51.58	58.53	63.11	59.81
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-31.36	-28.91	-30.66	24.22
Accounts Receivable, 5 Yr. CAGR %	-	-	-29.7	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-	69.61	70.84	81.77	35.39
Total Assets, 5 Yr. CAGR %	-	121.94	64.61	63.27	32.92
Tangible Book Value, 5 Yr. CAGR %	-	55.3	56.62	57.11	31.36
Common Equity, 5 Yr. CAGR %	-	58.86	75.91	71.52	28.01
Cash From Operations, 5 Yr. CAGR %	-	54.92	210.59	62.22	55.09
Capital Expenditures, 5 Yr. CAGR %	-	47.01	38.82	31.83	40.38
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	56.4	118.96	55.13
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	56.5	119.38	54.25